This small interfering RNA (siRNA) therapy works by inhibiting SerpinPC1 mRNA, reducing antithrombin levels, promoting ...

The incidence of chronic thromboembolic pulmonary hypertension is 6.5 per million person-years. 22 Applying these incidence rates to the 2000 US White population, approximately 1400 new chronic ...